HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Finding the right hemodialysis vascular access in the elderly: a patient-centered approach.

Abstract
Vascular access preparation in the elderly with advanced kidney disease needs a nuanced approach. Recent studies indicate that age, along with comorbidity, modify the outcomes associated with the type of access placed or used for hemodialysis (HD). Options ranging from permanent vascular access (arteriovenous fistula [AVF] or graft [AVG]) to tunneled central venous catheter (TCVC) or conservative medical care must be weighed on an individual basis and reassessed longitudinally. The potential benefits derived from AVF compared with AVG and TCVC are not always seen in this population. Herein, we review the literature concerning patient and vascular access outcomes in the elderly with advanced kidney disease or on HD. A multidimensional approach that takes into consideration the burden of comorbid diseases, functional status and patient-reported views on quality of life ought to be incorporated in the process of vascular access planning in the elderly.
AuthorsMariana Murea, John Burkart
JournalThe journal of vascular access (J Vasc Access) Vol. 17 Issue 5 Pg. 386-391 (Sep 21 2016) ISSN: 1724-6032 [Electronic] United States
PMID27516143 (Publication Type: Journal Article, Review)
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Arteriovenous Shunt, Surgical (adverse effects, mortality)
  • Blood Vessel Prosthesis Implantation (adverse effects, mortality)
  • Catheterization, Central Venous (adverse effects, mortality)
  • Comorbidity
  • Humans
  • Incidence
  • Kidney Failure, Chronic (diagnosis, mortality, therapy)
  • Prevalence
  • Quality of Life
  • Renal Dialysis (adverse effects, mortality)
  • Renal Insufficiency, Chronic (diagnosis, mortality, therapy)
  • Risk Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: